Home Top Movers Oncternal Therapeutics, Inc. (ONCT) Stock Price Soared By A Staggering 13.13%. Here’s...

Oncternal Therapeutics, Inc. (ONCT) Stock Price Soared By A Staggering 13.13%. Here’s What Happened.

Oncternal Therapeutics, Inc. (ONCT), a clinical-stage biopharmaceutical company specializing in manufacturing unique oncology therapies, announced the latest interim clinical data from the ongoing Phase 1/2 CIRLL (Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma) clinical trial, to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check in after-market trading, shares of Oncternal Therapeutics Inc. (ONCT) were up 13.13% at $6.29. ONCT’s stock closed the last session at $5.56, decreasing -4.14% or -$0.24. Shares of the company fluctuated between $5.37 and $5.67 throughout the day. The shares of Oncternal Therapeutics Inc. have advanced 9.45% in the last five days; however, they have lost -3.30% over the last month.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Updated Interim Data

In the CIRLL study, cirmtuzumab, a potential anti-ROR1 monoclonal antibody, is being assessed to be used with ibrutinib in patients affected with MCL and CLL. The clinical trial is being supervised in association with the UC San Diego School of Medicine and is partly funded by the California Institute for Regenerative Medicine.

Patients consisted of heavy risk factors and were stiffly pre-treated at study entry, 70% with a high Ki-67 proliferative index, 15% with intermediate to high prognostic score, and an average of two methodical previous therapies.

The ORR of 83% (with 15 out of a total 18 patients assessed), which was inclusive freshly registered patients with comparatively short follow-up time, and can be compared to the 87% ORR (13 of 15 evaluable patients) who were priorly presented at the American Society of Hematology (ASH) 2020 Annual Meeting.

Eight of 18 (44%) assessed patients partly got a response (PR) and two patients (11%) consisted of stable disease (SD), for a total clinical best benefit rate of 94%. The finished response rate was 39% (7 of 18 assessed patients)

The combination of cirmtuzumab and ibrutinib had had a high tolerance, with treatment usage producing harmful events and blood aberrations consistent with, or moderately lower than those reported for the only ibrutinib. No dose-limiting toxicities have been established and no serious negative scenarios are linked to cirmtuzumab alone.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Positive Interim data combined with a low rate of toxicity as compared to the only ibrutinib has surged investor interest for Oncternal Therapeutics, with ONCT stock price rising immensely at last check.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

Here is why Amneal Pharmaceuticals Inc (AMRX) stock soared on Monday?

Amneal Pharmaceuticals Inc. (AMRX) shares rose 7.18% in after-hours on Monday, July 19, 2021, and closed at $4.63 per share. Earlier in the morning,...

Why Applied DNA Sciences Inc. (APDN) stock had a bad Friday?

Applied DNA Sciences Inc. (APDN) shares fell 5.27% in after-hours on Friday, July 16, 2021, at $5.03 per share. Earlier, APDN's stock lost 2.93%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam